Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
Ontology highlight
ABSTRACT: The use of bispecific antibodies (BsAbs) to treat human diseases is on the rise. Increasingly complex and powerful therapeutic mechanisms made possible by BsAbs are spurring innovation of novel BsAb formats and methods for their production. The long-lived in vivo pharmacokinetics, optimal biophysical properties and potential effector functions of natural IgG monoclonal (and monospecific) antibodies has resulted in a push to generate fully IgG BsAb formats with the same quaternary structure as monoclonal IgGs. The production of fully IgG BsAbs is challenging because of the highly heterogeneous pairing of heavy chains (HCs) and light chains (LCs) when produced in mammalian cells with two IgG HCs and two LCs. A solution to the HC heterodimerization aspect of IgG BsAb production was first disc
SUBMITTER: Froning KJ
PROVIDER: S-EPMC5606552 | biostudies-literature | 2017 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA